InMed Pharmaceuticals (INM) Profit After Tax (2021 - 2025)
Historic Profit After Tax for InMed Pharmaceuticals (INM) over the last 5 years, with Q3 2025 value amounting to -$1.7 million.
- InMed Pharmaceuticals' Profit After Tax fell 158.23% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.2 million, marking a year-over-year decrease of 1981.13%. This contributed to the annual value of -$8.2 million for FY2025, which is 649.35% down from last year.
- InMed Pharmaceuticals' Profit After Tax amounted to -$1.7 million in Q3 2025, which was down 158.23% from -$1.8 million recorded in Q2 2025.
- In the past 5 years, InMed Pharmaceuticals' Profit After Tax ranged from a high of -$338391.0 in Q2 2023 and a low of -$7.9 million during Q2 2022
- Its 5-year average for Profit After Tax is -$2.6 million, with a median of -$2.1 million in 2022.
- Per our database at Business Quant, InMed Pharmaceuticals' Profit After Tax skyrocketed by 9570.03% in 2023 and then plummeted by 47983.84% in 2024.
- Over the past 5 years, InMed Pharmaceuticals' Profit After Tax (Quarter) stood at -$4.3 million in 2021, then surged by 50.94% to -$2.1 million in 2022, then increased by 29.65% to -$1.5 million in 2023, then tumbled by 74.2% to -$2.6 million in 2024, then soared by 32.94% to -$1.7 million in 2025.
- Its Profit After Tax stands at -$1.7 million for Q3 2025, versus -$1.8 million for Q2 2025 and -$2.1 million for Q1 2025.